马超，中国疾病预防控制中心免疫规划中心循证室主任，研究员，公共卫生硕士导师，CFETP责任导师，美国CDC访问学者，中组部第八批援疆干部。从事疫苗和免疫规划相关工作，包括疫苗可预防疾病监测与防控、疫苗免疫策略研究、疫苗使用技术指南制定、疫苗上市后研究、疫苗相关突发事件应急处置等领域工作。
兼任WHO免疫战略专家咨询委员会（SAGE）麻疹风疹疫苗专家组成员，中国科协联合国咨商生命科学与人类健康专委会委员，《中华流行病学杂志》《中国疾病控制杂志》《疾病监测》青年编委，中国疫苗行业协会预防接种专业青年委员会委员；承担多项国际组织合作和国内疫苗与免疫研究课题，发表中英文学术文章30余篇。
科研项目
1.世界卫生组织项目：Risk factors for measles infection and susceptibility in China after nationwide measles vaccination campaign
2.中国疾病预防控制中心青年基金：接种含流腮成分疫苗对流行性腮腺炎保护效果现场研究
3.中国疾病预防控制中心：8月龄和18月龄接种麻腮风疫苗免疫效果观察
4.盖茨基金项目：支持中国循证决策和新疫苗纳入国家免疫规划
5. 国家科技重大专项：肠道病毒EV71疫苗人群免疫策略研究- EV71疫苗大规模使用的安全性研究
近期部分成果
l Chao Ma，Lixin Hao，Yan Zhang，et al. Monitoring progress towards the elimination of measles in China: epidemiological observations, implications and next steps[J]. Bull World Health Organ, 2014, 92(5):340-347.
l 马超，罗会明，李黎，等.世界卫生组织各区域及部分国家消除麻疹免疫策略[J]. 中国疫苗和免疫, 2014, 20(3): 252-260.
l Xiang Zheng, Ningjing Zhang, Xiaoshu Zhang, Lixin Hao, Qiru Su, Haijun Wang,Kongyan Meng, Binglin Zhang, Jianfeng Liu, Huaqing Wang, Huiming Luo, Li Li,Hui Li,Chao Ma. Investigation of a Measles Outbreak in China to Identify Gaps in Vaccination Coverage, Routes of Transmission, and Interventions[J]. PLoS One, 2015, 10(7): e0133983.
l C. Ma，F. Li，X. Zheng, et al. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013[J]. BMC Infect Dis, 2015, 15: 23.
l 马超，郝利新，苏琪茹，等.世界卫生组织194个成员国麻疹、流行性腮腺炎、风疹减毒活疫苗常规免疫程序、报告接种率与发病水平现状分析[J]. 中国疫苗和免疫, 2015, 21(3): 251-247.
l C. Ma，C. J. Gregory，L. Hao, et al. Risk factors for measles infection in 0-7 month old children in China after the 2010 nationwide measles campaign: A multi-site case-control study,2012-2013[J]. Vaccine, 2016, 34(51):6553-6560.
l L. Hao，C. Ma，K. A.Wannemuehler, et al. Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013[J]. Vaccine, 2016,34(51): 6545-6552.
l Ma C, Liu Y, Tang J, Jia H, Qin W, Su Y, et al. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China. Human vaccines & immunotherapeutics. 2018:1-6.
l C. Ma，S. Yan，Q. Su, et al.Measles transmission among adults with spread to children during an outbreak:Implications for measles elimination in China, 2014[J]. Vaccine, 2016, 34(51): 6539-6544.
l Chao Ma，Lance Rodewald，Zhijie An，et al. The National Immunization Advisory Committee in China:Roles of National Experts in Making Evidence-BasedRecommendations for Immunization[J]. China CDC Weekly, 2019, 1(2): 28-30.
l C. Ma，L. Rodewald，L. Hao, et al. Progress Toward Measles Elimination - China, January 2013-June 2019[J]. MMWR Morb Mortal Wkly Rep, 2019, 68(48): 1112-1116.
l C. Ma，L. Hao，L. Rodewald，et al. Risk factors for measles virus infection and susceptibility in persons aged 15 years and older in China: A multi-site case-control study, 2012-2013[J]. Vaccine, 2020, 38(16): 3210-3217.
